Management of Diabetic complications (polyneuropathy)

A clinical study in the management of Diabetic Polyneuropathy with Rasayan vati - DPN

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/07/009075

Enrollment

Registered

2017-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetic polyneuropathy

Interventions

Intervention1: Rasayan Vati: Rasayan Vati contains Aamalaki(Fruit of Emblica officinalis Gaertn),Gokshur (Fruit of Tribulus terrestris Linn) , Guduchi (Stem of Tinospora cordifolia.All three drugs in

Eligibility

Inclusion criteria

Inclusion criteria: Metabolically stable type 2 diabetic patients with symptoms of diabetic sensory-motor Polyneuropathy

Exclusion criteria

Exclusion criteria: who are treated with Insulin. Patients with other metabolic or endocrine disorders. Patients with other causes of Polyneuropathy. Patients suffering from infectious diseases. Patient with non-healing ulcer/ulcers. Patient with Disabling Diabetic Polyneuropathy

Design outcomes

Primary

Measure	Time frame
Neuropathy Symptoms Score (NSS) Michigan Neuropathy Screening Instrument (MNSI)Timepoint: 8 weeks	—

Secondary

Measure	Time frame
scale for quality of life(WHO-QoL BREF)in diabetic neuropathy, Deha Bala, Agni Bala, and Chetas Bala.Timepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDr Niranjan Y

Parul Institute Of Ayurved

ayurniranjan@gmail.com9448982866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026